KORU Medical Systems Income Statement (2010-2026) | KRMD

Income Statement Aug2010 Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Feb2015 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
5.53M6.04M6.49M6.24M6.55M7.76M7.34M7.39M6.94M7.00M7.19M8.20M8.43M8.18M8.84M9.64M10.19M10.40M10.90M11.76M
Cost of Revenue (Quarter)
2.32M2.54M2.66M2.62M3.20M3.44M3.27M3.25M3.05M2.66M2.85M3.09M2.95M2.99M3.28M3.59M3.72M4.14M4.08M4.53M
Gross Profit (Quarter)
3.21M3.50M3.83M3.62M3.35M4.32M4.08M4.15M3.89M4.34M4.33M5.10M5.48M5.19M5.56M6.05M6.48M6.26M6.82M7.23M
Operating items
Depreciation & Amortization - Total (Quarter)
0.10M0.10M0.09M0.11M0.15M0.20M0.21M0.20M0.21M0.22M0.23M
Research & Development (Quarter)
0.39M0.80M0.95M1.15M1.30M0.86M1.64M1.56M1.60M1.29M1.29M1.48M1.13M1.53M1.11M1.11M1.19M0.93M1.14M1.32M
Selling, General & Administrative (Quarter)
4.09M3.90M4.88M5.49M5.53M4.83M4.76M5.43M5.30M4.62M5.01M5.36M5.32M5.13M5.83M5.96M5.38M5.99M6.04M6.58M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)
0.02M0.02M0.11M0.02M0.02M0.02M0.19M0.02M0.02M0.23M0.02M0.21M0.22M0.21M0.20M0.18M0.20M
Operating Expenses (Quarter)
4.59M4.82M5.94M6.75M6.96M5.85M6.59M7.20M7.11M6.13M6.53M7.06M6.67M6.89M7.15M7.29M6.79M7.13M7.36M8.10M
Operating Income (Quarter)
-1.38M-1.32M6.25M-3.13M-3.61M-1.53M-2.51M-3.06M-3.22M-1.79M-2.20M-1.96M-1.19M-1.70M-1.59M-1.25M-0.31M-0.87M2.97M-0.86M
EBIT (Quarter)
-1.38M-1.32M6.25M-3.13M-3.61M-1.53M-2.51M-3.06M-3.22M-1.79M-2.20M-1.96M-1.19M-1.70M-1.59M-1.25M-0.31M-0.87M2.97M-0.86M
Non-operating items
Interest & Investment Income (Quarter)
0.11M0.08M0.07M0.07M0.07M0.08M
Other Non Operating Income (Quarter)
0.01M-0.01M0.03M-0.00M-0.02M-0.01M-977.00-680.00-0.00M0.14M0.57M-0.01M0.21M0.01M-0.03M0.01M0.08M0.01M0.05M-0.02M
Non Operating Income (Quarter)
0.01M-0.01M0.65M-0.01M-0.02M0.04M0.10M0.07M0.13M0.14M0.17M0.03M0.21M0.12M-0.37M0.08M0.12M0.09M0.35M0.06M
Net income details
EBT (Quarter)
-1.37M-1.33M-1.44M-3.14M-3.63M-1.50M-2.41M-2.99M-3.10M-1.67M-2.02M-1.94M-0.99M-1.58M-1.56M-1.17M-0.19M-0.78M-0.48M-0.81M
Tax Provisions (Quarter)
-0.25M-0.24M-0.38M-0.60M-0.71M-0.27M-0.43M-0.58M-0.60M-0.30M5.45M0.02M-150.00-0.04M
Profit After Tax (Quarter)
-1.12M-1.09M-1.07M-2.54M-2.92M-1.23M-1.98M-2.41M-2.50M-1.37M-7.47M-1.94M-0.99M-1.58M-1.56M-1.17M-0.21M-0.78M-0.49M-0.81M
Income from Continuing Operations (Quarter)
-1.12M-1.09M-1.07M-2.54M-2.92M-1.23M-1.98M-2.41M-2.50M-1.37M-7.47M-1.94M-0.99M-1.58M-1.56M-1.17M-0.21M-0.78M-0.44M-0.81M
Consolidated Net Income (Quarter)
-1.12M-1.09M-1.07M-2.54M-2.92M-1.23M-1.98M-2.41M-2.50M-1.37M-7.47M-1.94M-0.99M-1.58M-1.56M-1.17M-0.21M-0.78M-0.44M-0.81M
Income towards Parent Company (Quarter)
-1.12M-1.09M-1.07M-2.54M-2.92M-1.23M-1.98M-2.41M-2.50M-1.37M-7.47M-1.94M-0.99M-1.58M-1.56M-1.17M-0.21M-0.78M-0.44M-0.81M
Net Income towards Common Stockholders (Quarter)
-1.12M-1.09M-1.07M-2.54M-2.92M-1.23M-1.98M-2.41M-2.50M-1.37M-7.47M-1.94M-0.99M-1.58M-1.56M-1.17M-0.21M-0.78M-0.44M-0.81M
Additional items
EPS (Basic) (Quarter)
-0.03-0.02-0.02-0.06-0.07-0.03-0.04-0.05-0.05-0.03-0.160.04-0.02-0.03-0.03-0.030.00-0.02-0.01-0.02
EPS (Weighted Average and Diluted) (Quarter)
-0.03-0.02-0.02-0.06-0.07-0.03-0.04-0.05-0.05-0.03-0.160.040.020.03-0.23-0.030.000.02-0.11-0.02
Shares Outstanding (Weighted Average) (Quarter)
44.23M44.32M44.39M44.67M44.80M44.88M45.00M45.49M45.61M45.58M45.60M45.71M45.76M45.85M45.80M45.98M49.66M49.71M46.19M46.36M
Shares Outstanding (Diluted Average) (Quarter)
44.23M44.51M44.39M44.67M44.92M44.88M45.00M45.49M45.61M45.64M45.60M45.71M45.76M45.79M45.80M45.98M46.09M46.24M46.19M46.36M
EBITDA (Quarter)
-1.28M-1.22M6.25M-3.03M-3.50M-1.38M-2.51M-2.86M-3.01M-1.59M-2.20M-1.75M-0.97M-1.48M-1.59M-1.25M-0.31M-0.87M2.97M-0.86M
Interest Expenses (Quarter)
Tax Rate (Quarter)
17.91%17.88%26.02%19.06%19.56%18.14%18.03%19.32%19.38%17.99%-269.44%-9.16%0.02%8.11%